Piper Sandler has recently initiated Cigna Group (CI) stock to Overweight rating, as announced on June 26, 2024, according to Finviz. Earlier, on May 30, 2024, Robert W. Baird had initiated the stock to Outperform, setting a price target of $388. Barclays also initiated Overweight rating with a price target of $393. Additionally, RBC Capital Mkts raised Outperform rating on February 5, 2024, with a target price of $354. Cantor Fitzgerald analysts, in their report published on February 5, 2024, also raised Overweight rating and set a price target of $334 for Cigna Group’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
Cigna Group (CI) Stock Trading Recap
On Thursday, Cigna Group (CI) stock saw a decline, ending the day at $355.12 which represents a decrease of $-11.52 or -3.14% from the prior close of $366.64. The stock opened at $362.06 and touched a low of $348.8 during the day, reaching a high of $364.41. The volume of shares traded was 2.52 million exceeding the average volume of 1.34 million.
CI Stock Performance and Moving Averages
In recent trading, Cigna Group (CI) stock price has shown some volatility, fluctuating -0.79% over the last five trades and 7.84% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by 4.50%, and it has gained 6.27% in the previous three months. Currently, CI is trading at 2.58%, 4.60%, and 7.65% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, CI, a Healthcare sector stock, is trading -4.19% below its 52-week high but remains 39.84% above its 52-week low. The Average True Range (ATR) (14 days) of 7.33 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Cigna Group’s Profitability and Valuation Ratios
Cigna Group’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 3.53% and a profit margin of 1.72%, with a gross margin of 4.50%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Cigna Group’s market capitalization stands at $99.27 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The stock’s price-to-earnings (P/E) ratio is 27.93, assessing the company’s valuation relative to its earnings. The forward P/E ratio, which uses projected earnings for the next financial year, is 11.16. Additionally, the Price-to-Sales Ratio is 0.46, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 2.4, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.88% of Cigna Group (CI)’s shares, while financial institutions hold 89.75%.
Notable insider trades include DeLaney William J III, Director at Cigna Group (CI), who sold 2691 shares on Aug 19 ’24, at $342.68 each, totaling $0.92 million. On Aug 12 ’24, Jones Nicole S, See Remarks, sold 22030 shares for $330.96 each, amounting to $7.29 million. Additionally, on Aug 12 ’24, Triplett Michael W sold 6819 shares at $329.94 each, generating $2.25 million.
